Świerczek, A.; Szafarz, M.; Cios, A.; Kobierski, J.; Pociecha, K.; Attard Saliba, D.; Chłoń-Rzepa, G.; Wyska, E.
Pharmacokinetics and Quantitative Structure–Pharmacokinetics Relationship Study of Xanthine Derivatives with Antidepressant, Anti-Inflammatory, and Analgesic Activity in Rats. Pharmaceutics 2024, 16, 1463.
https://doi.org/10.3390/pharmaceutics16111463
AMA Style
Świerczek A, Szafarz M, Cios A, Kobierski J, Pociecha K, Attard Saliba D, Chłoń-Rzepa G, Wyska E.
Pharmacokinetics and Quantitative Structure–Pharmacokinetics Relationship Study of Xanthine Derivatives with Antidepressant, Anti-Inflammatory, and Analgesic Activity in Rats. Pharmaceutics. 2024; 16(11):1463.
https://doi.org/10.3390/pharmaceutics16111463
Chicago/Turabian Style
Świerczek, Artur, Małgorzata Szafarz, Agnieszka Cios, Jan Kobierski, Krzysztof Pociecha, Daniel Attard Saliba, Grażyna Chłoń-Rzepa, and Elżbieta Wyska.
2024. "Pharmacokinetics and Quantitative Structure–Pharmacokinetics Relationship Study of Xanthine Derivatives with Antidepressant, Anti-Inflammatory, and Analgesic Activity in Rats" Pharmaceutics 16, no. 11: 1463.
https://doi.org/10.3390/pharmaceutics16111463
APA Style
Świerczek, A., Szafarz, M., Cios, A., Kobierski, J., Pociecha, K., Attard Saliba, D., Chłoń-Rzepa, G., & Wyska, E.
(2024). Pharmacokinetics and Quantitative Structure–Pharmacokinetics Relationship Study of Xanthine Derivatives with Antidepressant, Anti-Inflammatory, and Analgesic Activity in Rats. Pharmaceutics, 16(11), 1463.
https://doi.org/10.3390/pharmaceutics16111463